Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A2A Receptor

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES(2023)

引用 0|浏览2
暂无评分
摘要
Cannabidiol (CBD) is a phytocannabinoid with potential as a therapy for a variety of diseases. CBD may act via cannabinoid receptors but also via other G-protein-coupled receptors (GPCRs), including the adenosine A(2A) receptor. Homogenous binding and signaling assays in Chinese hamster ovary (CHO) cells expressing the human version of the A(2A) receptor were performed to address the effect of CBD on receptor functionality. CBD was not able to compete for the binding of a SCH 442416 derivative labeled with a red emitting fluorescent probe that is a selective antagonist that binds to the orthosteric site of the receptor. However, CBD reduced the effect of the selective A(2A) receptor agonist, CGS 21680, on G(s)-coupling and on the activation of the mitogen activated kinase signaling pathway. It is suggested that CBD is a negative allosteric modulator of the A(2A )receptor.
更多
查看译文
关键词
MAPK,ERK phosphorylation,cAMP,cannabinoids,cannabinoid receptors,adenosine receptors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要